Preclinical molecule development is a crucial step in bringing innovative therapies to patients. Optimizing the efficacy of these medicines requires rigorous understanding of their pharmacokinetic (PK) and pharmacodynamic (PD) properties. Comprehensive preclinical DMPK services offer a diverse range of analyses designed to elucidate the fate and e